期刊文献+

胆汁淤积性瘙痒发病机制和治疗进展 被引量:3

原文传递
导出
摘要 瘙痒被定义为一种可以引发搔抓欲望的不愉快的皮肤黏膜感觉.这种感觉无论在性质、持续性及定位上均不同于触觉和痛觉。瘙痒是各种皮肤疾病的主要症状,但亦可出现在其他疾病中.如胆汁淤积综合征、尿毒症、甲状腺功能亢进、干燥综合征等。瘙痒出现于70%~80%的胆汁淤积患者,常为中度.瘙痒的存在本身无预后价值,并不反映疾病内在的严重程度.但10%的患者可很严重并影响生活质量,甚至引发自杀倾向和行为。
出处 《内科理论与实践》 2014年第5期348-351,共4页 Journal of Internal Medicine Concepts & Practice
  • 相关文献

参考文献25

  • 1Kremer AE, Beuers U, Oude-Elferink RP, et al. Patho- genesis and treatment of pruritus in cholestasis[J]. Drugs, 2008, 68(15): 2163-2182.
  • 2Bergasa NV. The itch of liver disease[J]. Semin Cutan Med Surg, 2011, 30(2): 93-98.
  • 3Imam MH, Gossard AA, Sinakos E, et al. Pathogenesis and management of pruritus in cholestatic liver disease [J]. J Gastroenterol Hepatol, 2012, 27(7): 1150-1158.
  • 4Jones DE. Pathogenesis of cholestatic itch: old ques- tions, new answers, and future opportunities[J]. Hepatol- ogy, 2012, 56(4): 1194-1196.
  • 5Nakanaga K, Hama K, Aoki J. Autotaxin an LPA pro- ducing enzyme with diverse functions[J]. J Bioehem, 2010, 148(1): 13-24.
  • 6Khurana S, Singh P. Rifampin is safe for treatment of pru- ritus due'to chronic cholestasis: a meta-analysis of prospective randomized-controlled triMs[J]. Liver Int, 2006, 26(8): 943-948.
  • 7Dillon S, Tobias JD. Ondansetron to treat pruritus due to cholestatic jaundice[J]. J Pediatr Pharmacol Ther, 2013, 18(3): 241-246.
  • 8Leckie P, Tritto G, Mookerjee R, et al. 'Out-patient' al- bumin dialysis for cholestatic patients with intractable pruritus[J]. Aliment Pharmacol Ther, 2012, 35(6): 696-704.
  • 9Beuers U, Kremer AE, Bolier R, et al. Pruritus in cholesta- sis: facts and fiction[J]. Hepatology, 2014, 60(1): 399-407.
  • 10Ricci P, Hofmann AF, Hagey LR, et al. Adjuvant cholyl- sarcosine during ursodeoxycholic acid treatment of pri- mary biliary cirrhosis[J]. Dig Dis Sci, 1998, 43(6): 1292- 1295.

同被引文献35

  • 1林辰,钟江.壮医药线点灸结合中药内服治疗脂溢性皮炎疗效观察[J].云南中医学院学报,2006,29(S1). 被引量:6
  • 2庞宇舟.壮医药线点灸结合壮药治疗老年性皮肤瘙痒疗效观察[J].中国民族医药杂志,2005,11(6):12-12. 被引量:6
  • 3Carey E J, Ali AH, Lindor KD. Primary biliary cirrhosis[J].Lancet, 2015, 386(10003): 1565-1575.
  • 4Gasser RW. Cholestasis and metabolic bone disease-a clinical review[J]. Wien Med Wochenschr, 2008, 158(19-20): 553-557.
  • 5Pusl T, Beuers U. Extrahepatic manifestations of cholestatic liver diseases: pathogenesis and therapy[J]. Clin Rev Allergy Immunol, 2005, 28(2): 147-157.
  • 6Bolier R, Oude Elferink RP, Beuers U. Advances in pathogenesis and treatment of pruritus[J]. Clin Liver Dis, 2013, 17(2): 319-329.
  • 7Bunchomtavakul C, Reddy KR. Pruritus in chronic cholestatic liver disease[J]. Clin Liver Dis, 2012, 16(2): 331-346.
  • 8Hegade VS, Kendrick SF, Jones DE. Drug treatment of pruritus in liver diseases[J]. Clin Med (Lond), 2015, 15(4): 351-357.
  • 9Kremer AE, Bolier R, van Dijk R, et al. Advances in pathogenesis and management of pruritus in cholestasis[J]. Dig Dis, 2014, 32(5): 637-645.
  • 10EASL Clinical Practice Guidelines:management of cholestatic liver diseases[J]. J Hepatol, 2009, 51(2): 237-267.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部